-
How GLP-1s Are Reshaping Consumer Behavior
It’s been about a month since FNCE 2025 in Nashville, and I’m still sifting through my notes and revisiting the sessions I loved. One that stood out was the panel “The GLP-1 Effect: Understanding Consumer Behavior Shifts and Their Impact on Food, Nutrition, and Innovation.” The sheer scale of GLP-1 adoption and the depth of the data presented were striking. What made the session even more compelling was its interdisciplinary perspective, bringing together insights from industry leaders, physicians, RDs, and AI-generated consumer modeling. GLP-1 medications are reshaping metabolic health, culture, consumer expectations, and the future of the food landscape. Here…
-
Dizziness and Wegovy: What’s the Connection?
I’ve recently had an increasing number of patients report dizziness while taking Wegovy (semaglutide). This has been observed in both newly prescribed patients and those who have been on the medication for over a year. The dizziness appears distinct from more common side effects such as nausea, vomiting, diarrhea, and constipation. It occurs suddenly and unpredictably but is consistently present. What could be causing this dizziness in patients using Wegovy for weight loss? Let’s explore the science to better understand this phenomenon. What is Wegovy? Wegovy is a once weekly prescription medication containing semaglutide, which is used for chronic weight…
